Magnolia Medical Appoints Jason Richey as President and CEO

Strategic Insights -

Jason Richey has been appointed as President and Chief Executive Officer of Magnolia Medical Technologies, a leading developer of blood and bodily fluid collection systems, effective July 14, 2025. With over 20 years of experience leading innovative medical technology companies, Richey brings a proven track record of scaling high-growth MedTech organizations across global markets. His appointment comes at a pivotal time for Magnolia Medical, as the company's innovations continue to accelerate the adoption of a new standard of care for blood culture testing.

Key Takeaways:

  • Jason Richey has been appointed as President and CEO of Magnolia Medical Technologies, effective July 14, 2025, bringing over 20 years of experience in leading MedTech companies.
  • Richey's appointment is a pivotal moment for Magnolia Medical, as the company's innovations continue to accelerate the adoption of a new standard of care for blood culture testing.
  • The company's clinically proven technologies, such as the Initial Specimen Diversion Technique (ISDT) and Initial Specimen Diversion Device (ISDD), have been endorsed by leading medical societies and have resulted in improved patient outcomes.
  • Magnolia Medical has developed a robust intellectual property portfolio with over 200 issued patents and more than 50 pending applications.
  • The company's founder, Greg Bullington, has contributed significantly to the development and early commercialization of the Steripath Initial Specimen Diversion Device platform.
  • Jason Richey is committed to expanding the company's impact, delivering exceptional value to customers, and supporting its continued growth.

Statistics:

  • Nearly 10 million blood cultures have been performed in U.S. hospitals using the Steripath platform to detect bloodstream infections, including sepsis.
  • The Steripath platform has improved blood culture accuracy, reducing avoidable costs and unnecessary antibiotic use.
  • Montage Medical has built a robust intellectual property portfolio encompassing hundreds of novel device designs and integrated diagnostic technologies.
  • The company holds over 200 issued patents and more than 50 pending applications.

Sources:

  • "Magnolia Medical Technologies, Inc. Appoints Jason Richey as President and CEO." PRNewswire, July 29, 2025.
  • Magnolia Medical Technologies. About. Viewed July 29, 2025.